Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chaim Lichtig is active.

Publication


Featured researches published by Chaim Lichtig.


American Journal of Dermatopathology | 1995

The pattern of HMB-45 antibody staining in compound Spitz nevi

Reuven Bergman; Rachel Dromi; Herni Trau; Isaac Cohen; Chaim Lichtig

We studied the staining pattern of HMB-45 antibody in 29 compound Spitz nevi (SNs) of the epithelioid cell variety, 17 of which showed extension of nevus cells into the reticular dermis (i.e., “deep”); 20 ordinary compound nevi (CNs), all with a deep dermal component; and 22 primary cutaneous invasive malignant melanomas (MMs) (excluding the desmoplastic and spindle cell types), 12 of which extended into Clark level IV or V. Of the 29 SNs, eight (28%) stained negatively; five (17%), including two deep SNs, stained in the epidermal component only; and 16 (55%), including 10 deep SNs, stained in both the epidermal and dermal components. Of the latter 10 deep SNs, eight stained in the upper dermis only, and in the remaining two lesions, a smaller number of positively stained nevus cells were detectable in the lower dermis as well; these two SNs were not atypical histologically. Of the 20 CNs, four (20%) stained negatively, two (10%) stained in the epidermal component only, and 14 (70%) stained in the epidermal component and the upper dermis only. Of the 22 MMs, one stained negatively, and 21 (95%) stained positively in both the epidermal and dermal components. The pattern was variable in frequency of both staining and distribution, but showed no stratification. We conclude that the majority of our positively stained deep compound SNs showed a stratified pattern of HMB-45 staining, similar to ordinary CNs and different from MMs, and that this pattern might be used as an adjunct in the histopathologic differential diagnosis of compound SN and MM, in the proper clinicopathological context.


Diseases of The Colon & Rectum | 1995

Mast cells in colorectal neoplasias and premalignant disorders

Jesse Lachter; Moshe Stein; Chaim Lichtig; Shmuel Eidelman; Marianna Munichor

PURPOSE: Mast cells have recently been found to be well correlated with the prognosis of patients with rectal cancer. This work aimed to characterize the role of mast cells in colonic premalignant conditions. METHODS: Mast cells were quantified in various colonic disorders, particularly those with premalignant potential. Possible avenues of mast cell action were investigated using these tissue samples, by measuring basement membrane and collagen layer thickening. RESULTS: The mean number of mast cells in carcinoma sections was 0.967/0.9 mm2, in various colorectal neoplasias and related conditions it ranged from 1.36–3/0.9 mm2, and in normal histologic specimens it was 11.90/0.9 mm2. These data established statistically significant differences in mast cell numbers in the colonic disorders studied. The number of mast cells is greatest in the lamina propria level of the colon, a site often not examined because of the limited depth of samples obtained from endoscopic biopsies. CONCLUSIONS: Mast cell numbers were found to be correlated to the development from premalignancy to colonic malignancy. Mast cells may be useful as markers of colorectal neoplasia.


American Journal of Dermatopathology | 1994

Epithelial Markers in Malignant Melanoma: A Study of Primary Lesions and Their Metastases

Ofer Ben-Izhak; Paula Stark; Rivka Levy; Reuven Bergman; Chaim Lichtig

: In order to determine epithelial markers in malignant melanoma in routinely processed paraffin sections and to compare the staining of primary (cutaneous) malignant melanomas and their metastases, we stained formalin-fixed paraffin sections of 13 primary and 18 metastatic malignant melanomas using the streptavidin-biotin peroxidase method by antibodies to S-100, vimentin, HMB-45, polyclonal carcinoembryonic antigen (CEA), monoclonal CEA, cytokeratins (CAM 5.2 and broad-spectrum CKKES), and epithelial membrane antigen (EMA). All primary and most metastatic malignant melanomas showed positive staining with anti-S-100, HMB-45, and anti-vimentin. Reactivity with polyclonal CEA was observed in 15 (48%) of the 31 lesions; 14 of them were metastatic. No lesion was reactive with monoclonal CEA. Significant cytokeratin (CK) staining was evident in only three (9.7%) lesions (all metastatic), which also stained specifically with anti-CK 18. EMA was observed only focally in two (6.5%) lesions. There was no correlation between epithelial markers staining of the primary tumours and their metastases. All lesions with CK or EMA staining showed concomitant extensive staining for S-100, HMB-45, and vimentin. We conclude that (a) polyclonal CEA staining in malignant melanoma is not rare and is probably due to CEA-related molecules; (b) significant CK reactivity is rare and related to simple CK, such as CK 18; (c) epithelial marker reactivity is more common in metastases of malignant melanomas and is not correlated to the reactivity in their primary tumors. Considering our results and reports of positive S-100, vimentin, and HMB-45 in epithelial tumors, a wide panel of antibodies is recommended for the study of undifferentiated tumors.


American Journal of Dermatopathology | 1995

Immunohistochemical study of p53 protein expression in Spitz nevus as compared with other melanocytic lesions.

Reuven Bergman; Avner Shemer; Rivka Levy; Rachel Friedman-Birnbaum; Henri Trau; Chaim Lichtig

The accumuluation of p53 protein was studied immunohistochemically on paraffin-embedded sections of 26 Spitz nevi (SNs), 26 primary invasive cutaneous malignant melanomas (MMs), 20 metastases of MM, and 17 ordinary compound nevi (CNs), using monoclonal antibody BP53–12. Positive reactivity was detected in some of the tumor cells in seven (35%) metastatic MMs, all exhibiting strong nuclear staining; eight (31%) primary MMs, of which seven showed strong nuclear staining; two (7%) SNs, of which only one showed strong nuclear staining; and none of the CNs. The frequencies of the positively stained lesions in general, and the strongly positively stained lesions in particular, in the MM and metastatic MM groups were each statistically significantly higher than the respective frequencies in the SN and CN groups. We believe that the immunohistochemical detection of p53 protein with the use of monoclonal antibodies such as BP53–12 on paraffin sections, especially when strong nuclear reactivity is demonstrated, may prove to be an adjunctive tool in the histopathologic differentiation of MM from SN.


Cancer | 1988

Subclavian artery occlusion after radiotherapy for carcinoma of the breast.

Moshe Hashmonai; Amir Elami; Abraham Kuten; Chaim Lichtig; Shlomo Torem

Disturbance of the arterial circulation in the ipsilateral upper limb following mastectomy is a rare sequel attributed to adjuvant radiotherapy. A review of the literature revealed 20 such cases, and two more are presented. Different mechanisms of injury leading to arterial occlusion have been proposed. This is a late complication with a considerable time lag between irradiation and onset of symptoms. The symptoms vary in type and severity, but are consistent with peripheral occlusive arterial disease. To alleviate symptoms and prevent limb loss, reconstructive vascular surgery is advocated, and was successfully performed in one of our patients.


American Journal of Dermatopathology | 1992

Porokeratotic eccrine ostial and dermal duct nevus. An abnormally keratinizing epidermal invagination or a dilated, porokeratotically plugged acrosyringium and dermal duct?

Reuven Bergman; Chaim Lichtig; Aurica Cohen; Rachel Friedman-Birnbaum

Porokeratotic eccrine ostial and dermal duct nevus (PEODDN) has been said to represent a widely dilated, keratin-plugged acrosyringium and dermal duct. We have observed in a case of congenital PEODDN a normal-appearing, acrosyringium-like duct that traverses vertically the entire length of the parakeratotic column. Also, in its lower course, it stained positively for carcinoembryonic antigen, while the inner borders of the invagination from which the parakeratotic column arose stained negatively. This leads us to suggest that the epithelial structure in PEODDN is an abnormally keratinizing epidermal invagination through which an acrosyringium-like duct traverses, rather than an abnormally dilated, parakeratotically plugged acrosyringium and dermal duct.


Clinical and Experimental Dermatology | 1990

An immunofluorescence study of primary anetoderma.

Reuven Bergman; Rachel Friedman-Birnbaum; B. Hazaz; E. Cohen; M. Munichor; Chaim Lichtig

Primary anetoderma (PA) has occasionally been described in association with lupus erythematosus (LE). The present study was performed to elucidate a possible causal link between PA and LE by the use of direct and indirect immunofluorescence (IF) methods. Two patients with PA were studied. Biopsy specimens were obtained from early inflammatory and atrophic anetoderma lesions and from the exposed and unexposed uninvolved skin of each patient. The pattern of immune deposits observed in one patient was indistinguishable from that which is often seen in systemic LE, and in the other patient from that which may be observed in chronic cutaneous LE. The direct IF study also showed fibrillar immune deposits in the dermis that resembled elastic fibres morphologically. The indirect IF study, however, failed to demonstrate anti‐elastic fibre antibodies in the patientssera. The results of this study and a review of the literature suggest that some cases of PA have direct IF findings similar to those of either chronic cutaneous or systemic LE. However, these findings, along; with the serological findings, are insufficient to establish a diagnosis of LE in most of these PA cases.


Journal of The American Academy of Dermatology | 1992

Malignant melanomas with histologic diameters less than 6 mm

Reuven Bergman; Ilan Katz; Chaim Lichtig; Yehudith Ben-Arieh; Aharon R. Moscona; Rachel Friedman-Birnbaum

BACKGROUND Malignant melanomas (MMs) with a small diameter (less than 6 mm) are rarely removed surgically; therefore there is a need for more data to characterize them. OBJECTIVE The purpose of this study was to further elucidate the clinical and histopathologic features of small melanomas. METHODS The greatest diameters of 112 consecutively submitted MMs were measured histologically. Those lesions with diameters of less than 6 mm were further studied clinically and histopathologically. RESULTS Four MMs (3.5%) were found to have small histologic diameters. Their clinical features differed from the classic clinical ABCDs, although their histopathologic features resembled those of large MMs. Their depth of dermal invasion was relatively superficial, and their clinical outcome was favorable. CONCLUSION Histopathologically, small MMs tend to resemble large MMs, but clinically they may require other diagnostic criteria. Because they tend to show a relatively superficial depth of invasion, their increased recognition and removal may have an impact on overall mortality from MM.


Cancer | 1992

Epithelioid angiosarcoma of the adrenal gland with cytokeratin expression report of a case with accompanying mesenteric fibromatosis

Ofer Ben-Izhak; Lya Auslander; Suzana Rabinson; Chaim Lichtig; Ahud Sternberg

A case report of epithelioid adrenal angiosarcoma is presented. Tumor cells showed expression of cytokeratin, Factor VIII‐related antigen, Ulex europaeus agglutinin‐I, and vimentin. The patient also was found to have mesenteric fibromatosis (abdominal desmoid tumor) and an elevated serum level of estradiol. The authors discuss the unique appearance of these rare tumors, their relationship to hyperestrinism, and review the recent data in the literature showing cytokeratin expression by malignant epithelioid vascular tumors.


American Journal of Dermatopathology | 1996

An Immunohistochemical Study of p53 Protein Expression in Classical Kaposi's Sarcoma

Reuven Bergman; Michal Ramon; Sigalit Kilim; Chaim Lichtig; Rachel Friedman-Birnbaum

The present study was performed to determine the frequency of p53 protein immunoreactivity in classical Kaposis sarcoma (KS) as a whole and in relation to the histological subtypes which are considered to correspond to the developmental stages of the tumor. The accumulation of p53 protein was studied immunohistochemically using monoclonal antibody BP53-12 on formalin-fixed paraffin-embedded sections of 36 KS lesions, of which 14 were classified histologically as early type and 22 as spindle-cell or mixed type. No positive immunoreactivity was detected in any of the 14 early-type lesions. Among the 22 spindle-cell and mixed variants, positive staining was detected in 5-10% of the tumor cells in one lesion, 1-5% of the cells in six lesions, and in < 1% of the cells in two lesions. These very small percentages of positively stained cells in less than half of the cases of the spindle-cell and mixed variants do not support a significant role for p53 in tumor progression and evolution in KS.

Collaboration


Dive into the Chaim Lichtig's collaboration.

Top Co-Authors

Avatar

Rachel Friedman-Birnbaum

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Reuven Bergman

Rambam Health Care Campus

View shared research outputs
Top Co-Authors

Avatar

Ruth M. Ludatscher

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Joseph M. Brandes

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Eliezer Robinson

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ewy Meyer

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Joseph Levy

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ofer Ben-Izhak

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arie H. Bartal

Technion – Israel Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge